BIO Asia–Taiwan 2022 亞洲生技大會

BIO Asia–Taiwan 2022 亞洲生技大會

TEACHER

Tim Lu

Session 4 – Exit Strategies for Early Stage New Drug Companies

Date:27 July (Wednesday)
Time:  14:00 – 15:30 (GMT+8)

Tim Lu

Co-founder and CEO
Senti Biosciences, Inc.

Senti’s co-founder and CEO, Dr. Lu, is a pioneer in synthetic biology with strong ties to Harvard University, where he received his M.D., and the Massachusetts Institute of Technology, or MIT, where he received his Ph.D. in Electrical and Biomedical Engineering and started his academic lab in 2010. Tim founded Senti with co-founder and CTO Philip Lee in 2016 with the goal to bring synthetic biology into next-generation cell and gene therapies to treat important diseases. He has received numerous awards including the NIH New Innovator Award, US President Early Career Award for Scientists and Engineers, MIT Technology Review’s TR35, Navy and Army Young Investigator Prizes and others.

Speech title & Synopsis

.

.